Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New radiation approach aims to tame prostate cancer with fewer side effects

NCT ID NCT07552168

First seen May 21, 2026 · Last updated May 23, 2026 · Updated 1 time

Summary

This study tests a newer, more precise type of radiation therapy (SABR) for men with low to high-risk prostate cancer. The goal is to see if this approach can control the cancer while reducing side effects like urinary and bowel problems. About 136 men will receive the treatment and be followed for up to 5 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bon Secours - UPMC Hillman

    RECRUITING

    Cork, T12 DV56, Ireland

    Contact Phone: •••-•••-••••

    Contact

  • Northern Ireland Cancer Centre (NICC)

    NOT_YET_RECRUITING

    Belfast, Ulster, BT9 7AB, United Kingdom

    Contact Phone: •••-•••-••••

    Contact

  • St Luke's Centre for Radiation Oncology at Beaumont Hospital

    NOT_YET_RECRUITING

    Dublin, Leinster, D09 FT51, Ireland

    Contact

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.